{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:28:08Z","timestamp":1792783688848,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bau Tsu Zung Bau Kwan Yeu Hing Research and Clinical Fellowship","award":["Bau Tsu Zung Bau Kwan Yeu Hing Research and Clinical Fellowship"],"award-info":[{"award-number":["Bau Tsu Zung Bau Kwan Yeu Hing Research and Clinical Fellowship"]}]},{"name":"EU\/EFPIA Innovative Medicines Initiative Joint Undertaking BigData@Heart grant","award":["116074"],"award-info":[{"award-number":["116074"]}],"id":[{"id":"https:\/\/ror.org\/019af4n30","id-type":"ROR","asserted-by":"crossref"}]},{"name":"British Heart Foundation Centre of Research Excellence","award":["RE\/18\/4\/34215"],"award-info":[{"award-number":["RE\/18\/4\/34215"]}],"id":[{"id":"https:\/\/ror.org\/02wdwnk04","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["225790\/Z\/22\/Z"],"award-info":[{"award-number":["225790\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Medical Research Council","award":["MC_UU_00002\/7"],"award-info":[{"award-number":["MC_UU_00002\/7"]}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/13\/13\/30194; RG\/18\/13\/33946"],"award-info":[{"award-number":["RG\/13\/13\/30194; RG\/18\/13\/33946"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BHF Cambridge CRE","award":["RE\/18\/1\/34212"],"award-info":[{"award-number":["RE\/18\/1\/34212"]}]},{"DOI":"10.13039\/501100018956","name":"National Institute for Health Research Cambridge Biomedical Research Centre","doi-asserted-by":"crossref","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100023699","name":"Health Data Research UK","doi-asserted-by":"publisher","award":["Health Data Research UK"],"award-info":[{"award-number":["Health Data Research UK"]}],"id":[{"id":"10.13039\/501100023699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Plasma low-density lipoprotein (LDL)-cholesterol is positively associated with coronary artery disease risk while biliary cholesterol promotes gallstone formation. Different plasma LDL-cholesterol lowering pathways may have distinct effects on biliary cholesterol and thereby gallstone disease risk. We conducted a Mendelian randomization (MR) study using data from the UK Biobank (30,547 gallstone disease cases\/336,742 controls), FinnGen (34,461 cases\/301,383 controls) and Biobank Japan (9,305 cases\/168,253 controls). We first performed drug-target MR analyses substantiated by colocalization to investigate the effects of plasma LDL-cholesterol lowering therapies on gallstone disease risk. We then performed clustered MR analyses and pathway analyses to identify distinct mechanisms underlying the association of plasma LDL-cholesterol with gallstone disease risk. For a 1-standard deviation reduction in plasma LDL-cholesterol, genetic mimics of statins were associated with lower gallstone disease risk (odds ratio 0.72 [95% confidence interval 0.62, 0.83]), but genetic mimics of PCSK9 inhibitors and targeting apolipoprotein B were associated with higher risk (1.11 [1.03, 1.19] and 1.23 [1.13, 1.35]). The association for statins was supported by colocalization (posterior probability 98.7%). Clustered MR analyses identified variant clusters showing opposing associations of plasma LDL-cholesterol with gallstone disease risk, with some evidence for ancestry-and sex-specific associations. Among variants lowering plasma LDL-cholesterol, those associated with lower gallstone disease risk were mapped to glycosphingolipid biosynthesis pathway, while those associated with higher risk were mapped to pathways relating to plasma lipoprotein assembly, remodelling, and clearance and ATP-binding cassette transporters. This MR study provides genetic evidence that different plasma LDL-cholesterol lowering pathways have opposing effects on gallstone disease risk.<\/jats:p>","DOI":"10.1007\/s10654-024-01141-5","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T13:01:56Z","timestamp":1721048516000},"page":"857-867","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Multi-biobank Mendelian randomization analyses identify opposing pathways in plasma low-density lipoprotein-cholesterol lowering and gallstone disease"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-386X","authenticated-orcid":false,"given":"Guoyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipender","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Mary","family":"Schooling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5365-8760","authenticated-orcid":false,"given":"Stephen","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"issue":"32","key":"1141_CR1","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459\u201372. https:\/\/doi.org\/10.1093\/eurheartj\/ehx144","journal-title":"Eur Heart J"},{"key":"1141_CR2","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","volume":"2","author":"F Lammert","year":"2016","unstructured":"Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Primers. 2016;2:16024. https:\/\/doi.org\/10.1038\/nrdp.2016.24","journal-title":"Gallstones Nat Reviews Disease Primers"},{"issue":"15","key":"1141_CR3","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","volume":"388","author":"SE Nissen","year":"2023","unstructured":"Nissen SE, Lincoff AM, Brennan D, et al. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med. 2023;388(15):1353\u201364. https:\/\/doi.org\/10.1056\/NEJMoa2215024","journal-title":"N Engl J Med"},{"issue":"9784","key":"1141_CR4","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/s0140-6736(11)60739-3","volume":"377","author":"C Baigent","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet (London England). 2011;377(9784):2181\u201392. https:\/\/doi.org\/10.1016\/s0140-6736(11)60739-3","journal-title":"Lancet (London England)"},{"issue":"18","key":"1141_CR5","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1001\/jama.2009.1601","volume":"302","author":"M Bodmer","year":"2009","unstructured":"Bodmer M, Brauchli YB, Kr\u00e4henb\u00fchl S, Jick SS, Meier CR. Statin use and risk of gallstone disease followed by cholecystectomy. JAMA. 2009;302(18):2001\u20137. https:\/\/doi.org\/10.1001\/jama.2009.1601","journal-title":"JAMA"},{"issue":"2","key":"1141_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/aje\/kwq361","volume":"173","author":"R Erichsen","year":"2011","unstructured":"Erichsen R, Fr\u00f8slev T, Lash TL, Pedersen L, S\u00f8rensen HT. Long-term statin use and the risk of gallstone disease: a population-based case-control study. Am J Epidemiol. 2011;173(2):162\u201370. https:\/\/doi.org\/10.1093\/aje\/kwq361","journal-title":"Am J Epidemiol"},{"issue":"8","key":"1141_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133\u201363. https:\/\/doi.org\/10.1002\/sim.3034","journal-title":"Stat Med"},{"issue":"4","key":"1141_CR8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/hep.32183","volume":"75","author":"L Chen","year":"2022","unstructured":"Chen L, Yang H, Li H, He C, Yang L, Lv G. Insights into modifiable risk factors of cholelithiasis: a Mendelian randomization study. Hepatology (Baltimore MD). 2022;75(4):785\u201396. https:\/\/doi.org\/10.1002\/hep.32183","journal-title":"Hepatology (Baltimore MD)"},{"issue":"3","key":"1141_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/gutjnl-2023-330784","volume":"73","author":"L Chen","year":"2024","unstructured":"Chen L, Qiu W, Sun X, et al. Novel insights into causal effects of serum lipids and lipid-modifying targets on cholelithiasis. Gut. 2024;73(3):521\u201332. https:\/\/doi.org\/10.1136\/gutjnl-2023-330784","journal-title":"Gut"},{"issue":"1","key":"1141_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jhep.2012.08.013","volume":"58","author":"S Stender","year":"2013","unstructured":"Stender S, Frikke-Schmidt R, Benn M, Nordestgaard BG, Tybj\u00e6rg-Hansen A. Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses. J Hepatol. 2013;58(1):126\u201333. https:\/\/doi.org\/10.1016\/j.jhep.2012.08.013","journal-title":"J Hepatol"},{"issue":"20","key":"1141_CR11","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.jacc.2013.12.055","volume":"63","author":"S Stender","year":"2014","unstructured":"Stender S, Frikke-Schmidt R, Nordestgaard BG, Tybj\u00e6rg-Hansen A. The ABCG5\/8 cholesterol transporter and myocardial infarction versus gallstone disease. J Am Coll Cardiol. 2014;63(20):2121\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2013.12.055","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"1141_CR12","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/eurheartj\/ehv108","volume":"36","author":"BK Lauridsen","year":"2015","unstructured":"Lauridsen BK, Stender S, Frikke-Schmidt R, Nordestgaard BG, Tybj\u00e6rg-Hansen A. Genetic variation in the cholesterol transporter NPC1L1, ischaemic vascular disease, and gallstone disease. Eur Heart J. 2015;36(25):1601\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehv108","journal-title":"Eur Heart J"},{"issue":"22","key":"1141_CR13","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1093\/eurheartj\/ehy068","volume":"39","author":"F Qayyum","year":"2018","unstructured":"Qayyum F, Lauridsen BK, Frikke-Schmidt R, Kofoed KF, Nordestgaard BG, Tybj\u00e6rg-Hansen A. Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease. Eur Heart J. 2018;39(22):2106\u201316. https:\/\/doi.org\/10.1093\/eurheartj\/ehy068","journal-title":"Eur Heart J"},{"issue":"4","key":"1141_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21(4):225\u201345. https:\/\/doi.org\/10.1038\/s41580-019-0190-7","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10199","key":"1141_CR15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/s0140-6736(19)31950-6","volume":"394","author":"KK Ray","year":"2019","unstructured":"Ray KK, Corral P, Morales E, Nicholls SJ. Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options. Lancet (London England). 2019;394(10199):697\u2013708. https:\/\/doi.org\/10.1016\/s0140-6736(19)31950-6","journal-title":"Lancet (London England)"},{"issue":"24","key":"1141_CR16","doi-asserted-by":"publisher","first-page":"e009876","DOI":"10.1161\/jaha.118.009876","volume":"7","author":"O Ahmed","year":"2018","unstructured":"Ahmed O, Littmann K, Gustafsson U, et al. Ezetimibe in combination with simvastatin reduces remnant cholesterol without affecting biliary lipid concentrations in gallstone patients. J Am Heart Association. 2018;7(24):e009876. https:\/\/doi.org\/10.1161\/jaha.118.009876","journal-title":"J Am Heart Association"},{"issue":"7726","key":"1141_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139. https:\/\/doi.org\/10.1038\/s41586-018-0579-z","journal-title":"Nature"},{"issue":"7944","key":"1141_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318. https:\/\/doi.org\/10.1038\/s41586-022-05473-8","journal-title":"Nature"},{"issue":"10","key":"1141_CR19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53(10):1415\u201324. https:\/\/doi.org\/10.1038\/s41588-021-00931-x","journal-title":"Nat Genet"},{"issue":"5","key":"1141_CR20","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383","journal-title":"PLoS Genet"},{"issue":"4","key":"1141_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/bioinformatics\/btaa778","volume":"37","author":"CN Foley","year":"2021","unstructured":"Foley CN, Mason AM, Kirk PDW, Burgess S. MR-clust: clustering of genetic variants in Mendelian randomization with similar causal estimates. Bioinf (Oxford England). 2021;37(4):531\u201341. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa778","journal-title":"Bioinf (Oxford England)"},{"issue":"5","key":"1141_CR22","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.32199","volume":"75","author":"CJ Fairfield","year":"2022","unstructured":"Fairfield CJ, Drake TM, Pius R, et al. Genome-wide analysis identifies gallstone-susceptibility loci including genes regulating gastrointestinal motility. Hepatology (Baltimore MD). 2022;75(5):1081\u201394. https:\/\/doi.org\/10.1002\/hep.32199","journal-title":"Hepatology (Baltimore MD)"},{"issue":"5","key":"1141_CR23","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.cell.2016.10.042","volume":"167","author":"WJ Astle","year":"2016","unstructured":"Astle WJ, Elding H, Jiang T, et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell. 2016;167(5):1415\u2013e2919. https:\/\/doi.org\/10.1016\/j.cell.2016.10.042","journal-title":"Cell"},{"issue":"7890","key":"1141_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","volume":"600","author":"SE Graham","year":"2021","unstructured":"Graham SE, Clarke SL, Wu KH, et al. The power of genetic diversity in genome-wide association studies of lipids. Nature. 2021;600(7890):675\u20139. https:\/\/doi.org\/10.1038\/s41586-021-04064-3","journal-title":"Nature"},{"issue":"4","key":"1141_CR25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1001\/jama.2018.20045","volume":"321","author":"BA Ference","year":"2019","unstructured":"Ference BA, Kastelein JJP, Ray KK, et al. Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease. JAMA. 2019;321(4):364\u201373. https:\/\/doi.org\/10.1001\/jama.2018.20045","journal-title":"JAMA"},{"issue":"11","key":"1141_CR26","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1806747","volume":"380","author":"BA Ference","year":"2019","unstructured":"Ference BA, Ray KK, Catapano AL, et al. Mendelian randomization study of ACLY and cardiovascular disease. N Engl J Med. 2019;380(11):1033\u201342. https:\/\/doi.org\/10.1056\/NEJMoa1806747","journal-title":"N Engl J Med"},{"issue":"11","key":"1141_CR27","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.6835","volume":"35","author":"S Burgess","year":"2016","unstructured":"Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35(11):1880\u2013906. https:\/\/doi.org\/10.1002\/sim.6835","journal-title":"Stat Med"},{"issue":"6","key":"1141_CR28","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961\u201374. https:\/\/doi.org\/10.1093\/ije\/dyw220","journal-title":"Int J Epidemiol"},{"issue":"20","key":"1141_CR29","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","volume":"32","author":"JR Staley","year":"2016","unstructured":"Staley JR, Blackshaw J, Kamat MA, et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinf (Oxford England). 2016;32(20):3207\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btw373","journal-title":"Bioinf (Oxford England)"},{"issue":"22","key":"1141_CR30","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinf (Oxford England). 2019;35(22):4851\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btz469","journal-title":"Bioinf (Oxford England)"},{"issue":"10","key":"1141_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","volume":"47","author":"M Nikpay","year":"2015","unstructured":"Nikpay M, Goel A, Won HH, et al. A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47(10):1121\u201330. https:\/\/doi.org\/10.1038\/ng.3396","journal-title":"Nat Genet"},{"issue":"7","key":"1141_CR32","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365. https:\/\/doi.org\/10.1002\/gepi.21758","journal-title":"Genet Epidemiol"},{"issue":"4","key":"1141_CR33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314. https:\/\/doi.org\/10.1002\/gepi.21965","journal-title":"Genet Epidemiol"},{"issue":"2","key":"1141_CR34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325. https:\/\/doi.org\/10.1093\/ije\/dyv080","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1141_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x","journal-title":"Eur J Epidemiol"},{"key":"1141_CR36","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1745-9125.1998.tb01268.x","volume":"36","author":"R Paternoster","year":"1998","unstructured":"Paternoster R, Brame R, Mazerolle P, Piquero A. Using the correct statistical test for equality of regression coefficients. Criminology. 1998;36:859\u201366. https:\/\/doi.org\/10.1111\/j.1745-9125.1998.tb01268.x","journal-title":"Criminology"},{"issue":"5","key":"1141_CR37","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","volume":"109","author":"V Zuber","year":"2022","unstructured":"Zuber V, Grinberg NF, Gill D, et al. Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches. Am J Hum Genet. 2022;109(5):767\u201382. https:\/\/doi.org\/10.1016\/j.ajhg.2022.04.001","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1141_CR38","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8(1):1826. https:\/\/doi.org\/10.1038\/s41467-017-01261-5","journal-title":"Nat Commun"},{"issue":"8","key":"1141_CR39","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1001\/jama.2012.8439","volume":"308","author":"D Preiss","year":"2012","unstructured":"Preiss D, Tikkanen MJ, Welsh P, et al. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA. 2012;308(8):804\u201311. https:\/\/doi.org\/10.1001\/jama.2012.8439","journal-title":"JAMA"},{"issue":"4","key":"1141_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00004836-199806000-00015","volume":"26","author":"S Tazuma","year":"1998","unstructured":"Tazuma S, Kajiyama G, Mizuno T, et al. A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy. J Clin Gastroenterol. 1998;26(4):287\u201391. https:\/\/doi.org\/10.1097\/00004836-199806000-00015","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"1141_CR41","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/0016-5085(90)91092-k","volume":"98","author":"GM Logan","year":"1990","unstructured":"Logan GM, Duane WC. Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation. Gastroenterology. 1990;98(6):1572\u20136. https:\/\/doi.org\/10.1016\/0016-5085(90)91092-k","journal-title":"Gastroenterology"},{"issue":"2","key":"1141_CR42","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/glycob\/cwv084","volume":"26","author":"B Binnington","year":"2016","unstructured":"Binnington B, Nguyen L, Kamani M, et al. Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling. Glycobiology. 2016;26(2):166\u201380. https:\/\/doi.org\/10.1093\/glycob\/cwv084","journal-title":"Glycobiology"},{"issue":"6","key":"1141_CR43","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/j.1440-1746.2010.06246.x","volume":"25","author":"BJ Lee","year":"2010","unstructured":"Lee BJ, Kim JS, Kim BK, et al. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL\/6J mice. J Gastroenterol Hepatol. 2010;25(6):1105\u201310. https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06246.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"1141_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/clinem\/dgac562","volume":"108","author":"G Yang","year":"2023","unstructured":"Yang G, Schooling CM, Statins. Type 2 diabetes, and body mass index: a univariable and multivariable Mendelian randomization study. J Clin Endocrinol Metab. 2023;108(2):385\u201396. https:\/\/doi.org\/10.1210\/clinem\/dgac562","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"1141_CR45","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jama.2016.14568","volume":"316","author":"LA Lotta","year":"2016","unstructured":"Lotta LA, Sharp SJ, Burgess S, et al. Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis. JAMA. 2016;316(13):1383\u201391. https:\/\/doi.org\/10.1001\/jama.2016.14568","journal-title":"JAMA"},{"issue":"6","key":"1141_CR46","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bpg.2006.05.004","volume":"20","author":"EA Shaffer","year":"2006","unstructured":"Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best practice & research. Clin Gastroenterol. 2006;20(6):981\u201396. https:\/\/doi.org\/10.1016\/j.bpg.2006.05.004","journal-title":"Clin Gastroenterol"},{"key":"1141_CR47","doi-asserted-by":"publisher","unstructured":"Schooling CM, Zhao JV, Au Yeung SL, Leung GM. Investigating pleiotropic effects of statins on ischemic heart disease in the UK Biobank using Mendelian randomisation. eLife. 2020;9. https:\/\/doi.org\/10.7554\/eLife.58567","DOI":"10.7554\/eLife.58567"},{"issue":"1","key":"1141_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12916-021-02013-5","volume":"19","author":"S Li","year":"2021","unstructured":"Li S, Schooling CM. A phenome-wide association study of genetically mimicked statins. BMC Med. 2021;19(1):151. https:\/\/doi.org\/10.1186\/s12916-021-02013-5","journal-title":"BMC Med"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-024-01141-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-024-01141-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-024-01141-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T23:36:43Z","timestamp":1726702603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-024-01141-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1141"],"URL":"https:\/\/doi.org\/10.1007\/s10654-024-01141-5","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"14 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been conducted using the UK Biobank Resource (Application number 98032). The UK Biobank obtained ethical approval from the North West Multi-centre Research Ethics Committee. The analysis of publicly available summary statistics does not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The UK Biobank participants provided written informed consent. Participants of the original studies of publicly available summary statistics also provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declared no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}